The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial

Detalles Bibliográficos
Autores principales: Feeney, Eoin, Wallace, Deborah, Cotter, Aoife, Tinago, Willard, McCarthy, Cormac, Keane, David, Hussain, Rabia, Alvarez Barco, Elena, Doran, Peter, Mallon, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247433/
https://www.ncbi.nlm.nih.gov/pubmed/32450915
http://dx.doi.org/10.1186/s13063-020-04407-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247433/
https://www.ncbi.nlm.nih.gov/pubmed/32450915
http://dx.doi.org/10.1186/s13063-020-04407-x

Ejemplares similares